Sequoia Financial Advisors
TLSIW icon

Sequoia Financial Advisors’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Sequoia Financial Advisors’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-62,187
Closed -$103K – 1370
2024
Q2 		$103K Hold
62,187
– – ﹤0.01% 1159
2024
Q1 		$62.2K Hold
62,187
– – ﹤0.01% 1133
2023
Q4 		$74K Hold
62,187
– – ﹤0.01% 1169
2023
Q3 		$23.6K Hold
62,187
– – ﹤0.01% 957
2023
Q2 		$3K Buy
+62,187
New +$4.22K ﹤0.01% 968

Other funds holding TLSIW

Vestcor Inc
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.56% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Alpha Capital Management
Alpha Capital Management Austin, Texas $770M AUM 23.14% 1-Year Est. Return
Cowen and Company
Cowen and Company New York $2.97B AUM 105.25% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
GTS Securities
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Sequoia Financial Advisors's TLSIW Position: Q3 2024 in Review

Sequoia Financial Advisors sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2024, closing a stake of 62,187 shares — an estimated $103K sold.

Sequoia Financial Advisors first reported a position in TLSIW in Q2 2023 and held it in 5 quarters. The position peaked at $103K in Q2 2024. 8 funds tracked by Wall St. Rank hold TLSIW as of Q3 2024.

  • Sequoia Financial Advisors reported no remaining TriSalus Life Sciences Warrant position as of Q3 2024 after selling out during the quarter.
  • Sequoia Financial Advisors sold 62,187 TriSalus Life Sciences Warrant shares in Q3 2024, an estimated $103K.
  • Sequoia Financial Advisors first reported a position in TriSalus Life Sciences Warrant in Q2 2023 and held it in 5 quarters.
  • Sequoia Financial Advisors's TriSalus Life Sciences Warrant position peaked at $103K in Q2 2024.
  • 8 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2024.

Based on Sequoia Financial Advisors's 13F filing for Q3 2024, filed 21 Oct 2024.